RxDoctor Payments Data

Regina Fiacco, PA

Medical · Corvallis, ORNPI 1518934751

Payments from drug & device makers

$844in general payments, 2019–2025

Across 42 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$167
  • Bayer$162
  • Smith+Nephew$107
  • AstraZeneca$89
  • GSK$86
  • Otsuka America Pharmaceutical, Inc.$66
  • plus $167 from 6 others

What the payments were for

  • Food & beverage$844100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$844 in reported general payments places this provider in the 70th percentile of 364 medical providers in Oregon.

See all medical providers in Oregon

Medicare billing

Part B allowed, 2024
$32,247
Medicare patients
68
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$13,571
OzempicSemaglutide11$12,692
Incruse ElliptaUmeclidinium Bromide12$4,205
Quetiapine Fumarate51$2,232
Levothyroxine Sodium93$1,403
Atorvastatin Calcium54$1,331
Venlafaxine Hcl ErVenlafaxine Hcl21$1,258
Aripiprazole15$1,006
Losartan Potassium62$866
Rosuvastatin Calcium35$841
Metoprolol Succinate41$822
Omeprazole61$802
Fluoxetine Hcl25$797
Amlodipine Besylate93$791
Gabapentin46$753

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$167$13,57116 claims
GSKIncruse Ellipta$86$4,20512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 364 medical providers in Oregon.

Other medical in Corvallis

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →